JESSICA VAUGHN, Attorney at Law, Wiley Rein

Jessica is an associate in Wiley’s Food & Drug practice. She provides clients with legal and regulatory support needed to design and implement regulatory strategies to advance products, including pharmaceuticals, medical devices, food products, and dietary supplements, through the premarket approval regimen of the U.S. Food and Drug Administration (FDA) and its European counterparts. She has experience in clinical trial development and review, pre-clinical testing review and protocol development, expedited program applications, and Investigational New Drug (IND) application and New Drug Application (NDA) planning, drafting, and filing.

With a doctorate in toxicology and over 10 years of experience in pharmaceuticals, Jessica brings a unique perspective to FDA and drug development issues. Prior to joining Wiley, she served as in-house counsel at a biotech company, and can provide an insider view to the issues facing pharmaceutical clients. Jessica’s scientific research experience allows her to review and advise on both early and late stage drug development issues, as well as allowing her to provide a critical eye during pharma and biotech transactional due diligence and litigation discovery activities.